Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense 'black holes': a post hoc magnetic resonance imaging analysis.

MLA

Zivadinov, Robert, et al. “Effect of Glatiramer Acetate Three-Times Weekly on the Evolution of New, Active Multiple Sclerosis Lesions into T1-Hypointense ‘Black Holes’: A Post Hoc Magnetic Resonance Imaging Analysis.” Journal of Neurology, vol. 262, no. 3, Mar. 2015, pp. 648–53. EBSCOhost, https://doi.org/10.1007/s00415-014-7616-0.

APA

Zivadinov, R., Dwyer, M., Barkay, H., Steinerman, J., Knappertz, V., & Khan, O. (2015). Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense “black holes”: a post hoc magnetic resonance imaging analysis. Journal of Neurology, 262(3), 648–653. https://doi.org/10.1007/s00415-014-7616-0

Chicago

Zivadinov, Robert, Michael Dwyer, Hadas Barkay, Joshua Steinerman, Volker Knappertz, and Omar Khan. 2015. “Effect of Glatiramer Acetate Three-Times Weekly on the Evolution of New, Active Multiple Sclerosis Lesions into T1-Hypointense ‘Black Holes’: A Post Hoc Magnetic Resonance Imaging Analysis.” Journal of Neurology 262 (3): 648–53. doi:10.1007/s00415-014-7616-0.